BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9352462)

  • 1. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New renin inhibitors containing novel analogues of statine.
    Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
    J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of potent, low molecular weight renin inhibitors.
    Sueiras-Diaz J; Jones DM; Szelke M; Deinum J; Svensson L; Westerlund C; Sohtell M
    J Pept Res; 1997 Oct; 50(4):248-61. PubMed ID: 9352463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of rat renin and their use in experimental hypertension.
    Beattie EC; Morton JJ; Leckie BJ; Sueiras-Diaz J; Jones DM; Szelke M
    J Hypertens Suppl; 1989 Dec; 7(6):S220-1. PubMed ID: 2698930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
    Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
    J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-conformation relationships of synthetic peptide inhibitors of human renin studied by resonance energy transfer and molecular modeling.
    Epps DE; Mao B; Staples DJ; Sawyer TK
    Int J Pept Protein Res; 1988 Jan; 31(1):22-34. PubMed ID: 3284834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
    Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
    Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
    Thaisrivongs S; Pals DT; Lawson JA; Turner SR; Harris DW
    J Med Chem; 1987 Mar; 30(3):536-41. PubMed ID: 3546690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.
    Poe M; Wu JK; Lin TY; Hoogsteen K; Bull HG; Slater EE
    Anal Biochem; 1984 Aug; 140(2):459-67. PubMed ID: 6385771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
    Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
    J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon.
    Tree M; Atrash B; Donovan B; Gamble J; Hallett A; Hughes M; Jones DM; Leckie B; Lever AF; Morton JJ
    J Hypertens; 1983 Dec; 1(4):399-403. PubMed ID: 6398331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
    Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
    J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR; Hui KY; Coletti C; Hollenberg NK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
    Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
    Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
    Johnson RL; Verschoor K
    J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.